187
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Endothelial-Related Biomarkers in Evaluation of Vascular Function During Progression of Sepsis After Severe Trauma: New Potential Diagnostic Tools in Sepsis

ORCID Icon, , , , , & show all
Pages 2773-2782 | Received 25 Apr 2023, Accepted 03 Jul 2023, Published online: 06 Jul 2023

References

  • Martin GS, Mannino DM, Eaton S, et al. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348(16):1546–1554. doi:10.1056/NEJMoa022139
  • Osborn TM, Tracy JK, Dunne JR, et al. Epidemiology of sepsis in patients with traumatic injury. Crit Care Med. 2004;32(11):2234–2240. doi:10.1097/01.CCM.0000145586.23276.0F
  • Bhavani SV, Carey KA, Gilbert ER, et al. Identifying novel sepsis subphenotypes using temperature trajectories. Am J Respir Crit Care Med. 2019;200(3):327–335. doi:10.1164/rccm.201806-1197OC
  • Seymour CW, Kennedy JN, Wang S, et al. Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis. JAMA. 2019;321(20):2003–2017. doi:10.1001/jama.2019.5791
  • Dimaggio C, Ayoung-Chee P, Shinseki M, et al. Traumatic injury in the United States: in-patient epidemiology 2000–2011. Injury. 2016;47(7):1393–1403. doi:10.1016/j.injury.2016.04.002
  • Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801–810. doi:10.1001/jama.2016.0287
  • Schenz J, Weigand MA, Uhle F. Molecular and biomarker-based diagnostics in early sepsis: current challenges and future perspectives. Expert Rev Mol Diagn. 2019;19(12):1069–1078. doi:10.1080/14737159.2020.1680285
  • Tianhang L, Bo W, Zhengmao L, et al. Autologous transplantation of endothelial progenitor cells to prevent multiple organ dysfunction syndromes in pig. J Trauma Acute Care Surg. 2013;74(2):508–515. doi:10.1097/TA.0b013e3182703420
  • T L, J S, Lu Z, et al. Potential role of caveolin-1 in regulating the function of endothelial progenitor cells from experimental MODS model. Mediators Inflamm. 2019;2019(8297391). doi:10.1155/2019/8297391
  • Joffre J, Hellman J, Ince C, et al. Endothelial responses in sepsis. Am J Respir Crit Care Med. 2020;202(3):361–370. doi:10.1164/rccm.201910-1911TR
  • Pons S, Arnaud M, Loiselle M, et al. Immune consequences of endothelial cells’ activation and dysfunction during sepsis. Crit Care Clin. 2020;36(2):401–413. doi:10.1016/j.ccc.2019.12.001
  • H F, Goodwin AJ, Chang E, et al. Endothelial progenitor cells and a stromal cell-derived factor-1alpha analogue synergistically improve survival in sepsis. Am J Respir Crit Care Med. 2014;189(12):1509–1519. doi:10.1164/rccm.201312-2163OC
  • X S, Seidle KA, Simms KJ, et al. Endothelial progenitor cells in the host defense response. Pharmacol Ther. 2022;108315. doi:10.1016/j.pharmthera.2022.108315
  • Guldner A, Maron-Gutierrez T, Abreu SC, et al. Expanded endothelial progenitor cells mitigate lung injury in septic mice. Stem Cell Res Ther. 2015;6(230). doi:10.1186/s13287-015-0226-7
  • Zahran AM, Elsayh KI, Mohamad IL, et al. Circulating endothelial cells and endothelial progenitor cells in pediatric sepsis. Pediatr Emerg Care. 2016;32(3):163–167. doi:10.1097/PEC.0000000000000727
  • Moussa MD, Santonocito C, Fagnoul D, et al. Evaluation of endothelial damage in sepsis-related ARDS using circulating endothelial cells. Intensive Care Med. 2015;41(2):231–238. doi:10.1007/s00134-014-3589-9
  • Li C, Wu Q, B L, et al. Detection and validation of circulating endothelial cells, a blood-based diagnostic marker of acute myocardial infarction. PLoS One. 2013;8(3):e58478. doi:10.1371/journal.pone.0058478
  • Martinez-Sales V, Sanchez-Lazaro I, Vila V, et al. Circulating endothelial cells in patients with heart failure and left ventricular dysfunction. Dis Markers. 2011;31(2):75–82. doi:10.1155/2011/757840
  • Takei Y, Yamada M, Saito K, et al. Increase in circulating ACE-positive endothelial microparticles during acute lung injury. Eur Respir J. 2019;54(4):1801188. doi:10.1183/13993003.01188-2018
  • Paudel KR, Panth N, Kim DW. Circulating endothelial microparticles: a key hallmark of atherosclerosis progression. Scientifica. 2016;2016(8514056):1–9. doi:10.1155/2016/8514056
  • Han WQ, Chang FJ, Wang QR, et al. Microparticles from patients with the acute coronary syndrome impair vasodilatation by inhibiting the Akt/eNOS-Hsp90 signaling pathway. Cardiology. 2015;132(4):252–260. doi:10.1159/000438782
  • Nieuwland R, Berckmans RJ, Mcgregor S, et al. Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood. 2000;95(3):930–935. doi:10.1182/blood.V95.3.930.003k46_930_935
  • Mostefai HA, Meziani F, Mastronardi ML, et al. Circulating microparticles from patients with septic shock exert protective role in vascular function. Am J Respir Crit Care Med. 2008;178(11):1148–1155. doi:10.1164/rccm.200712-1835OC
  • Jansen F, Yang X, Baumann K, et al. Endothelial microparticles reduce ICAM-1 expression in a microRNA-222-dependent mechanism. J Cell Mol Med. 2015;19(9):2202–2214. doi:10.1111/jcmm.12607
  • Curtis AM, Wilkinson PF, Gui M, et al. p38 mitogen-activated protein kinase targets the production of proinflammatory endothelial microparticles. J Thromb Haemost. 2009;7(4):701–709. doi:10.1111/j.1538-7836.2009.03304.x
  • Lacroix R, Sabatier F, Mialhe A, et al. Activation of plasminogen into plasmin at the surface of endothelial microparticles: a mechanism that modulates angiogenic properties of endothelial progenitor cells in vitro. Blood. 2007;110(7):2432–2439. doi:10.1182/blood-2007-02-069997
  • Vitkova V, Zivny J, Janota J. Endothelial cell-derived microvesicles: potential mediators and biomarkers of pathologic processes. Biomark Med. 2018;12(2):161–175. doi:10.2217/bmm-2017-0182
  • Mahmoud AM, Wilkinson FL, Mccarthy EM, et al. Endothelial microparticles prevent lipid-induced endothelial damage via Akt/eNOS signaling and reduced oxidative stress. FASEB J. 2017;31(10):4636–4648. doi:10.1096/fj.201601244RR
  • Pernomian L, Moreira JD, Gomes MS. In the view of endothelial microparticles: novel perspectives for diagnostic and pharmacological management of cardiovascular risk during diabetes distress. J Diabetes Res. 2018;2018(9685205):1–7. doi:10.1155/2018/9685205